BioSpace News Archive

-- Fireside chat, moderated by Soumit Roy, Ph.D. of JonesTrading, will be held on Wednesday, May 26, 2021 at 11:00 am ET -- -- Featured speakers will include hematologist Alan List, M.D. and geriatric oncologist Lodovico Balducci, M.D. --

Welltower ® Inc. (NYSE:WELL) announced today that it will participate in the 2021 RBC Capital Markets Global Healthcare Conference on May 19, 2021 and the Morgan Stanley Life After COVID Thematic Conference II on May 20 , 2021.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Chairman, President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at Bernstein’s 37th Annual Strategic Decisions Conference on Wednesday, June 2, 2021 , at 10:00 a.m. Eastern Time

Affron earns the exclusive right in the United States to the formulation and use of its saffron extract in connection with low mood support

- Stephen Boyer joined company as vice president, regulatory and quality affairs and Peter Pechan joined as vice president, gene therapy

Veeva Systems announced that more than 100 companies have adopted Veeva Vault Training to simplify role-based qualification, improve compliance, and unify training with other critical business processes.

Humanigen, Inc . (Nasdaq: HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab™, today announced that the Company’s management team will participate in a fireside chat at the Jefferies Healthcare Conference being held from June 1-4, 2021.

AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced that James Sapirstein, AzurRx President, CEO and Chairman, will present at the Rocky Mountain Microcap Conference on May 26, 2021.

The demand within the global market for budesonide inhaler has been rising on account advancements in the treatment of lung and respiratory diseases.

Increasing incidence of chronic diseases is fuelling the demand for fluorescence-activated sorters and laser-induced fluorescence probes, enabling growth in fluoro enzymatic assays market